A note to our advertising partners: Endpoints News joins the Financial Times family
I’m thrilled to share with you the exciting news that Endpoints News is now officially a part of the Financial Times family.
Today’s announcement is a wonderful testament to the editorial vision and execution of our newsroom and, importantly, to the advertising partners that have supported our independent journalism from day one, allowing us to become the biopharma industry’s trusted news authority.
When John and Arsalan founded the company in 2016, the mission was clear: deliver the best news product in biopharma and become an essential read for industry leaders across the globe. Seven years later, we now have 164,000 subscribers and a team of journalists and staff in the US, Europe, and Asia. We’re read daily by thousands of innovative biotechs and every top 50 pharmaceutical company in the world.
Our expanding newsroom is now helmed by Executive Editor Drew Armstrong. And our editorial ambitions continue to grow as we complement our breaking news and daily analysis with original scoops, in-depth features and live journalism at the industry’s most important gatherings.
All of this would not have been possible without the support of our advertising partners. And so, we thank you.
We know that your partnerships truly enrich the Endpoints community and play an important role in cultivating such a vibrant dialogue among our readers. And now, with the full support of the most respected global brand in business journalism, we can’t wait to continue to grow our work together in the months and years ahead — giving you even more innovative ways to engage our growing audience of biopharma and healthcare executives across the globe.
Here’s to an incredibly exciting next chapter,
Ryan McRae, Chief Revenue Officer